5,12-Naphthacenedione,10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)- structure
|
Common Name | 5,12-Naphthacenedione,10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)- | ||
|---|---|---|---|---|
| CAS Number | 88254-07-3 | Molecular Weight | 638.61900 | |
| Density | 1.59g/cm3 | Boiling Point | 899.2ºC at 760 mmHg | |
| Molecular Formula | C32H34N2O12 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 497.6ºC | |
| Name | 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin |
|---|---|
| Synonym | More Synonyms |
| Density | 1.59g/cm3 |
|---|---|
| Boiling Point | 899.2ºC at 760 mmHg |
| Molecular Formula | C32H34N2O12 |
| Molecular Weight | 638.61900 |
| Flash Point | 497.6ºC |
| Exact Mass | 638.21100 |
| PSA | 216.31000 |
| LogP | 0.20488 |
| Index of Refraction | 1.697 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| 5,12-Naphthacenedione, 10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-.α.- L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11- trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
| MRA-CN |
| 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin |
| cyanomorpholino-doxorubicin |
| 3'-Deamino-3'-(3-cyano-4-morpholinyl)adriamycin |